Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-5920 in Involutional Osteoporosis
NCT00212667Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Aug 2002
- Primary completion
- Sep 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of minodronic acid in involutional osteoporosis, sponsored by Ono Pharmaceutical. Started Aug 2002; status: completed.
02
Drugs
minodronic acid
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on NCT00212667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212667.